The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: velcade     Quarter: 2016Q3

Total Records: 602     Number of Pages: 31

DRUGNAME PT EventCount
VELCADE Oedema 8
VELCADE Orthostatic hypotension 8
VELCADE Tumour lysis syndrome 8
VELCADE Adverse drug reaction 7
VELCADE Adverse event 7
VELCADE Arthralgia 7
VELCADE Cytomegalovirus infection 7
VELCADE Disease progression 7
VELCADE Drug effect decreased 7
VELCADE Fluid retention 7
VELCADE Haemoglobin decreased 7
VELCADE Interstitial lung disease 7
VELCADE Liver function test increased 7
VELCADE Loss of consciousness 7
VELCADE Pain in extremity 7
VELCADE Perineal erythema 7
VELCADE Abdominal pain upper 6
VELCADE Cardiac discomfort 6
VELCADE Full blood count decreased 6
VELCADE Hepatic function abnormal 6

Total Records: 602     Number of Pages: 31